Clinical Trial Update: A Study to Evaluate the Safety of Neural Stem Cells in Patients With Parkinson's Disease [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety of neural stem cells in Parkinson's disease has completed. The update summarizes safety outcomes from this trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Neural stem cells

Snippet

Sponsor: Cyto Therapeutics Pty Limited | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED